The dividend yield represents the relationship between the distribution and the current price of a share and is usually expressed as a percentage. The current dividend yield for China Medical is 2.03 percent, which is just 0.33 percent above the average of 1.71 percent for this stock. Based on this dividend policy, analysts give China Medical a “neutral” rating.
In terms of sentiment and public perception, the analysis shows that the mood around China Medical has barely changed in recent weeks. The share therefore also receives a “neutral” rating in this category. Analysis of Discussion Strength, which measures market participants’ attention on social media, shows that there has been no exceptional activity related to China Medical over the past four weeks. The share is therefore given a “neutral” rating overall.
In comparison to the average annual performance of stocks in the healthcare sector, China Medical performs worse. With a return of -31.38 percent, the share is more than 9 percent below the sector average. The overall healthcare services industry posted a median return of -17.15 percent over the past 12 months. Here too, China Medical is significantly lower with a difference of 14.24 percent, resulting in a “Poor” rating in this category.
To assess whether a security is considered “overbought” or “oversold,” the Relative Strength Index (RSI), a commonly used indicator in technical analysis, is used. The 7-day RSI for China Medical is currently at 56.41 points, indicating that the stock cannot be classified as either overbought or oversold. The stock therefore receives a “neutral” rating in this category. The longer-term 25-day RSI also shows that China Medical is not overbought or oversold at 61.039, resulting in another Neutral rating. Overall, China Medical also receives a “neutral” rating in this analysis phase.
Should China Phoenix Healthcare investors sell immediately? Or is it worth getting started?
How will China Phoenix Healthcare develop now? Is it worth getting started or should investors sell? You can find out the answers to these questions and why you need to act now in the current China Phoenix Healthcare analysis.
China Phoenix Healthcare: Buy or Sell? Read more here…
